Tapewire

Nasdaq · USD

PCSA

Processa Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
8210
SEC CIK
0001533743
Parsed reports
296

Last 12 months

Inside the activity.

45 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 2026100
Apr 2026150
May 2026100
Jun 202690
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2021 Filed May 5, 2021 12:13 UTC Amendment SaleCommon Stock, $0.01 par value 5,000 $11.35 $56,750.00
Disclosure

SEC source: 0000919574-21-003214 · ownership.xml · nonDerivative · entry 1

BESSER JAMES E · CIK 0001512127 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,120,000

F1 · ownership.nature: These securities are directly owned by Manchester Explorer, L.P. and JEB Partners, L.P. These securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P.; these securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC.

F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
October 02, 2020 Filed Oct 13, 2020 18:33 UTC PurchaseCommon Shares 30,000 $4.04 $121,200.00
Disclosure

SEC source: 0000919574-20-006339 · ownership.xml · nonDerivative · entry 1

BESSER JAMES E · CIK 0001512127 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,000

Read SEC document
October 01, 2020 Filed Oct 5, 2020 21:31 UTC Amendment
Lin PatrickChief Business - Strategy Off
PurchaseCommon Stock 31,250 $4.00 $125,000.00
Disclosure

SEC source: 0001567619-20-017589 · doc1.xml · nonDerivative · entry 1

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,737

F1 · price: This amended Form 4 is being filed to correct the purchase price for the reported transaction.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 20:42 UTC
Lin PatrickChief Business - Strategy Off
PurchaseCommon Stock 31,250 $2.10 $65,625.00
Disclosure

SEC source: 0001567619-20-017572 · doc1.xml · nonDerivative · entry 1

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,737

Read SEC document
October 01, 2020 Filed Oct 5, 2020 17:33 UTC Amendment
Stanker James HChief Financial Officer
PurchaseCommon Stock 6,000 $4.00 $24,000.00
Disclosure

SEC source: 0001567619-20-017592 · doc1.xml · nonDerivative · entry 1

Stanker James H · CIK 0001681718 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,248

F1 · price: This amended Form 4 is being filed to correct the purchase price for the reported transaction.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 16:43 UTC
Stanker James HChief Financial Officer
PurchaseCommon Stock 6,000 $2.10 $12,600.00
Disclosure

SEC source: 0001567619-20-017574 · doc1.xml · nonDerivative · entry 1

Stanker James H · CIK 0001681718 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,248

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.